148 related articles for article (PubMed ID: 34854543)
1. Pediatric AML patients with acute-onset cardiomyopathy in the setting of Streptococcus viridans bacteremia after anthracyclines.
Sabet K; Panigrahi A; Chung J; Dayan Y
Pediatr Blood Cancer; 2022 Feb; 69(2):e29450. PubMed ID: 34854543
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines.
Mort MK; Sen JM; Morris AL; DeGregory KA; McLoughlin EM; Mort JF; Dunn SP; Abuannadi M; Keng MK
J Oncol Pharm Pract; 2020 Apr; 26(3):680-687. PubMed ID: 31500517
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review.
Hefti E; Blanco JG
Cardiovasc Toxicol; 2016 Jan; 16(1):5-13. PubMed ID: 25616318
[TBL] [Abstract][Full Text] [Related]
4. Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy.
Menon NM; Katsanis E; Khalpey Z; Whitlow P
Pediatr Blood Cancer; 2015 Jan; 62(1):166-8. PubMed ID: 25175922
[TBL] [Abstract][Full Text] [Related]
5. [Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report].
Urbanová D; Bubanská E; Hrebík M; Mladosievicová B
Klin Onkol; 2009; 22(1):34-7. PubMed ID: 19534438
[TBL] [Abstract][Full Text] [Related]
6. Anthracycline-related acute cardiotoxicity in a very young Omani patient with acute myeloid leukaemia.
Tony S; Mevada R; Joshi N
Cardiol Young; 2021 Mar; 31(3):464-467. PubMed ID: 33228820
[TBL] [Abstract][Full Text] [Related]
7. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
8. Cardiac toxicity after anthracycline chemotherapy in childhood.
Iarussi D; Indolfi P; Galderisi M; Bossone E
Herz; 2000 Nov; 25(7):676-88. PubMed ID: 11141677
[TBL] [Abstract][Full Text] [Related]
9. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.
Orgel E; Zung L; Ji L; Finklestein J; Feusner J; Freyer DR
Pediatr Blood Cancer; 2013 Sep; 60(9):1528-33. PubMed ID: 23441080
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.
Temming P; Qureshi A; Hardt J; Leiper AD; Levitt G; Ancliff PJ; Webb DK
Pediatr Blood Cancer; 2011 Apr; 56(4):625-30. PubMed ID: 21298750
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Association Study Identifies
Wang X; Singh P; Zhou L; Sharafeldin N; Landier W; Hageman L; Burridge P; Yasui Y; Sapkota Y; Blanco JG; Oeffinger KC; Hudson MM; Chow EJ; Armenian SH; Neglia JP; Ritchey AK; Hawkins DS; Ginsberg JP; Robison LL; Armstrong GT; Bhatia S
J Clin Oncol; 2023 Mar; 41(9):1758-1769. PubMed ID: 36508697
[TBL] [Abstract][Full Text] [Related]
12. [Anthracycline-induced cardiomyopathy].
Roul G; Cohen C; Lieber A
Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
[TBL] [Abstract][Full Text] [Related]
13. External validation of a heart failure risk score in patients with acute myeloid leukemia.
Doukas PG; Cascino GJ; Meng Z; Baldridge AS; Kang Y; Scherrer-Crosbie M; Akhter N
Leuk Lymphoma; 2023 Feb; 64(2):445-453. PubMed ID: 36331544
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapeutics-induced heart failure].
Paulides M; Wojnowski L
Med Klin (Munich); 2007 Jul; 102(7):574-8. PubMed ID: 17634876
[TBL] [Abstract][Full Text] [Related]
15. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
18. Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines.
Marcault C; Venton G; Gastaud L; Mannone L; Rey J; D'Incan E; Saillard C; Charbonnier A; Raynaud S; Vey N; Cluzeau T
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e76-e81. PubMed ID: 31865004
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
[TBL] [Abstract][Full Text] [Related]
20. Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.
Schloemer NJ; Brickler M; Hoffmann R; Pan A; Simpson P; McFadden V; Block J; Tower RL; Burke MJ
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e254-e258. PubMed ID: 28452856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]